Episode 261
We love to hear from our listeners. Send us a message.
This week's episode is one from the road, recorded in front of a live audience in Boston's Seaport neighborhood during the BIO conference (speci…
Published on 2 months, 1 week ago
Episode 260
We love to hear from our listeners. Send us a message.
On this week's episode of the Business of Biotech, Jennifer Hawks Bland, CEO of NewYorkBIO, shares insights on New York State's life sciences ec…
Published on 2 months, 2 weeks ago
Episode 259
We love to hear from our listeners. Send us a message.
On this week's episode, Barry Quart, CEO of Connect Biopharma, weighs in on the current state of engagement between drug developers and the FDA,…
Published on 2 months, 3 weeks ago
Episode 258
We love to hear from our listeners. Send us a message.
On this week's episode of the Business of Biotech, Tom Wells, Director of Life Sciences at 4C Associates, reveals why -- and how -- smart procur…
Published on 2 months, 4 weeks ago
Episode 257
We love to hear from our listeners. Send us a message.
On this week's episode, Thomas Levenson, MIT professor and author of So Very Small: How Humans Discovered The Microcosmos, Defeated Germs — And …
Published on 3 months ago
Episode 256
We love to hear from our listeners. Send us a message.
On this week's episode, Dr. Srinivas Rao, co-founder and CEO at atai Life Sciences, explains how his engineering background led him to the devel…
Published on 3 months, 1 week ago
Episode 255
We love to hear from our listeners. Send us a message.
On this week's episode, Yaniv Sneor, founder of the Mid Atlantic Bio Angels and CEO at Native State Therapeutics, explains how life science ange…
Published on 3 months, 2 weeks ago
Episode 254
We love to hear from our listeners. Send us a message.
On this week's episode, Michelle Werner, CEO at Alltrna, talks transfer RNA (tRNA) therapy with host Ben Comer and guest co-host Anna Rose Welch…
Published on 3 months, 3 weeks ago
Episode 253
We love to hear from our listeners. Send us a message.
On this week's episode of the Business of Biotech, Dr. Mark Eisner, EVP and Chief Medical Officer at Vir Bio, talks about the company's post-COV…
Published on 4 months ago
Episode 252
We love to hear from our listeners. Send us a message.
On today's episode, Tolga Tanguler, EVP and Chief Commercial Officer at Alnylam Pharmaceuticals, talks about commercializing RNAi therapies, how…
Published on 4 months, 1 week ago
If you like Podbriefly.com, please consider donating to support the ongoing development.
Donate